Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
The Lancet. Neurology
|
October 22, 2013
Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension
Claudia Trenkwalder, Heike Beneš, Ludger Grote, et al.
JMIR Research Protocols
|
September 20, 2023
Refocusing of Attention on Positive Events Using Monitoring-Based Feedback and Microinterventions for Patients With Chronic Musculoskeletal Pain in the PerPAIN Randomized Controlled Trial: Protocol for a Microrandomized Trial
Leonie Ader, Anita Schick, Martin Löffler, et al.
The Lancet. Neurology
|
October 24, 2015
Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial
Claudia Trenkwalder, K Ray Chaudhuri, Pablo Martinez-Martin, et al.
Pain
|
January 27, 2025
Early-life adversity as a predictor of fibromyalgia syndrome: the central role of perceived stress over endocrine stress indicators
Eva Beiner, Michelle Hermes, Julian Reichert, et al.
Scientific Reports
|
December 16, 2024
Perceived and endocrine acute and chronic stress indicators in fibromyalgia syndrome
Eva Beiner, Michelle Hermes, Julian Reichert, et al.
Trials
|
September 22, 2025
Conventional probe trabeculotomy versus microcatheter-assisted 360° trabeculotomy (PIRATE) in childhood glaucoma-study protocol for a randomized controlled trial
Julia V Stingl, Irene M Schmidtmann, Markus Schepers, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
The Lancet. Neurology
|
October 22, 2013
Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension
Claudia Trenkwalder, Heike Beneš, Ludger Grote, et al.
JMIR Research Protocols
|
September 20, 2023
Refocusing of Attention on Positive Events Using Monitoring-Based Feedback and Microinterventions for Patients With Chronic Musculoskeletal Pain in the PerPAIN Randomized Controlled Trial: Protocol for a Microrandomized Trial
Leonie Ader, Anita Schick, Martin Löffler, et al.
The Lancet. Neurology
|
October 24, 2015
Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial
Claudia Trenkwalder, K Ray Chaudhuri, Pablo Martinez-Martin, et al.
Pain
|
January 27, 2025
Early-life adversity as a predictor of fibromyalgia syndrome: the central role of perceived stress over endocrine stress indicators
Eva Beiner, Michelle Hermes, Julian Reichert, et al.
Scientific Reports
|
December 16, 2024
Perceived and endocrine acute and chronic stress indicators in fibromyalgia syndrome
Eva Beiner, Michelle Hermes, Julian Reichert, et al.
Trials
|
September 22, 2025
Conventional probe trabeculotomy versus microcatheter-assisted 360° trabeculotomy (PIRATE) in childhood glaucoma-study protocol for a randomized controlled trial
Julia V Stingl, Irene M Schmidtmann, Markus Schepers, et al.
Page
of 3